Wellgistics Health Reports Officer/Director Changes
Ticker: WGRX · Form: 8-K · Filed: Oct 6, 2025 · CIK: 2030763
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election
TL;DR
Wellgistics Health (WGH) filed an 8-K for officer/director changes effective Oct 1st.
AI Summary
Wellgistics Health, Inc. filed an 8-K on October 6, 2025, reporting changes effective October 1, 2025. The filing indicates a departure of directors or certain officers, the election of new directors, and the appointment of certain officers, along with details on compensatory arrangements for these officers. The company, formerly known as Danam Health, Inc., is incorporated in Delaware and headquartered in Tampa, Florida.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership and executive compensation can introduce uncertainty and potential shifts in company direction.
Key Players & Entities
- Wellgistics Health, Inc. (company) — Registrant
- Danam Health, Inc (company) — Former company name
- October 1, 2025 (date) — Effective date of reported events
- October 6, 2025 (date) — Filing date of the 8-K
- 3000 Bayport Drive Suite 950 Tampa, FL 33607 (location) — Principal executive offices address
FAQ
What specific changes occurred regarding directors and officers?
The 8-K filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, effective October 1, 2025.
When was Wellgistics Health, Inc. formerly known as?
Wellgistics Health, Inc. was formerly known as Danam Health, Inc., with a name change date of July 17, 2024.
What is the principal executive office address for Wellgistics Health, Inc.?
The principal executive offices are located at 3000 Bayport Drive Suite 950, Tampa, FL 33607.
What is the SIC code for Wellgistics Health, Inc.?
The Standard Industrial Classification (SIC) code is 5122 for Wholesale - Drugs Proprietaries & Druggists' Sundries.
What is the filing date of this 8-K report?
This 8-K report was filed on October 6, 2025.
Filing Stats: 1,404 words · 6 min read · ~5 pages · Grade level 11.7 · Accepted 2025-10-06 17:30:36
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share WGRX The Nasdaq
- $120,000 — will receive an annual cash retainer of $120,000, payable at the director's election in
- $400,000 — r. Patel to be paid an annual salary of $400,000 per year. Mr. Patel also is eligible fo
Filing Documents
- form8-k.htm (8-K) — 51KB
- ex10-1.htm (EX-10.1) — 23KB
- ex17.htm (EX-17) — 1KB
- ex17_001.jpg (GRAPHIC) — 531KB
- ex10-1_001.jpg (GRAPHIC) — 252KB
- ex10-1_002.jpg (GRAPHIC) — 265KB
- ex10-1_003.jpg (GRAPHIC) — 249KB
- ex10-1_004.jpg (GRAPHIC) — 268KB
- ex10-1_005.jpg (GRAPHIC) — 281KB
- ex10-1_006.jpg (GRAPHIC) — 315KB
- ex10-1_007.jpg (GRAPHIC) — 242KB
- ex10-1_008.jpg (GRAPHIC) — 292KB
- ex10-1_009.jpg (GRAPHIC) — 211KB
- ex10-1_010.jpg (GRAPHIC) — 308KB
- ex10-1_011.jpg (GRAPHIC) — 319KB
- ex10-1_012.jpg (GRAPHIC) — 286KB
- ex10-1_013.jpg (GRAPHIC) — 294KB
- ex10-1_014.jpg (GRAPHIC) — 296KB
- ex10-1_015.jpg (GRAPHIC) — 293KB
- ex10-1_016.jpg (GRAPHIC) — 283KB
- ex10-1_017.jpg (GRAPHIC) — 226KB
- ex10-1_018.jpg (GRAPHIC) — 307KB
- ex10-1_019.jpg (GRAPHIC) — 324KB
- ex10-1_020.jpg (GRAPHIC) — 308KB
- ex10-1_021.jpg (GRAPHIC) — 27KB
- ex10-1_022.jpg (GRAPHIC) — 81KB
- ex10-1_023.jpg (GRAPHIC) — 268KB
- ex10-1_024.jpg (GRAPHIC) — 322KB
- ex10-1_025.jpg (GRAPHIC) — 296KB
- ex10-1_026.jpg (GRAPHIC) — 273KB
- ex10-1_027.jpg (GRAPHIC) — 305KB
- ex10-1_028.jpg (GRAPHIC) — 289KB
- ex10-1_029.jpg (GRAPHIC) — 159KB
- ex10-1_030.jpg (GRAPHIC) — 48KB
- ex10-1_031.jpg (GRAPHIC) — 201KB
- ex10-1_032.jpg (GRAPHIC) — 222KB
- ex10-1_033.jpg (GRAPHIC) — 70KB
- 0001493152-25-017134.txt ( ) — 12244KB
- wgrx-20251001.xsd (EX-101.SCH) — 3KB
- wgrx-20251001_lab.xml (EX-101.LAB) — 33KB
- wgrx-20251001_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 6, 2025 WELLGISTICS HEALTH, INC. By: /s/ Prashant Patel Prashant Patel, President